Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Abacus Medicine

02 17Amgen Inc

03 1ORIFARM GROUP AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form : Solution For Infusion

Dosage Strength : 38.5mcg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

02

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

BLINATUMOMAB

Brand Name : BLINCYTO

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 35MCG

Packaging :

Approval Date :

Application Number : 125557

Regulatory Info :

Registration Country : USA

blank

03

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomabum

Brand Name : Blincyto

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 38.5mcg

Packaging :

Approval Date : 25/02/2016

Application Number : 65654

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form : Solution For Infusion

Dosage Strength : 38.5mcg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

05

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form : Solution For Infusion

Dosage Strength : 385mcg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

06

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form : Powder For Concentrate And Solution For Infusion

Dosage Strength : 38.5MCG

Packaging :

Approval Date : 16-12-2015

Application Number : 1151047001

Regulatory Info : Authorized

Registration Country : Spain

blank

07

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form : Solution For Injection

Dosage Strength : 38.5mcg

Packaging :

Approval Date : 23-11-2015

Application Number : 28105519314

Regulatory Info : Prescription

Registration Country : Denmark

blank

08

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form : Solution For Injection

Dosage Strength : 38.5mcg

Packaging :

Approval Date : 23-11-2015

Application Number : 2.01E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

09

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

BLINATUMOMAB

Brand Name : BLINCYTO

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 38.5MCG/VIAL

Packaging : 265ML TO 275ML (STARTING VOL)

Approval Date :

Application Number : 2450283

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

10

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form : INJ

Dosage Strength : 38.5mcg

Packaging : 3X1mcg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

11

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

12

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

13

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

14

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

15

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

16

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

17

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

18

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

19

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Blinatumomab

Brand Name : Blincyto

Dosage Form : Solution For Infusion

Dosage Strength : 38.5mcg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Not Marketed

Registration Country : Norway

blank